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OBJECTIVES METHODS 
CONCLUSIONS Propranolol is an amphipathic β-blocker drug
 used for its regulatory effects over blood
 pressure and anxiety levels. 
Recent studies have explored interactions of
 propranolol in various environments with
 respect to its pharmaceutical characteristics; i.e.
 cellular take-up, intracellular location, etc. 
We are interested in expanding the knowledge
 base of data and analysis on the relation
 between propranolol and β-, HP-β-, and γ
-cyclodextrins, with respect to solvent
 accessibility.  
The association constant of propranolol and β
-cyclodextrin and the Stern-Volmer quenching
 relationship with iodide were found by
 fluorescence spectroscopy.  
RESULTS 
BACKGROUND 
Propranolol hydrochloride is an amphipathic drug
 capable of interacting with cell membranes.  It has a
 MW of 295.81. 
Β-Cyclodextrin 
C42H20O35 
•MW of 1134.98 
• 6 glucopyranose units 
•forms inclusion complexes 
•Helps prevent quenching of included compounds 
Our observations show that the association constant of β-cyclodextrin
 and propranolol in the presence of potassium iodide is 152 M-1.
 Qualitative analysis shows the effects of quenching by potassium
 iodide, as with many salts. This is seen in the fluorescence spectra at
 0.04M KI and the Stern-Volmer plot. The Stern Volmer plot trendlines
 show the effects of adding increasingly higher concentrations of β
-cyclodextrin in order to enhance fluorescence of propranolol by
 sheltering it from the surrounding salt anions in solution. 
The association constant from a previous study was found to be 195
 M-1 by spectroscopic analysis and 239 M-1 by calorimetry. 
The results confirm that β-cyclodextrin increases fluorescence under
 quenching conditions. 
Inclusion Complex/Quenching Study – β-cyclodextrin 
Stock solutions of propranolol (1.0 x 10-3 M), β-cyclodextrin (16 mM),
 and Potassium Iodide (0.5 M) were created with 0.1M, pH=~7.0
 phosphate buffer as the solvent. Exactly 100µL of propranolol, a
 specified volume of 0.5M KI, and increasing volumes of β-CD were
 added to five 10mL volumetric flasks and diluted to achieve a final
 concentration of 10µM propranolol and 0mM, 1.5mM, 3mM, 6mM,
 and 12mM respective concentrations of β-CD. This was repeated for
 different specified final concentrations of KI, ranging from 0M to
 0.08M. Samples were then excited at 296nm in a Jobin Yvon Horiba




Fluorescence is the emission lower energy light when excited by high
-energy light, usually ultraviolet. Only certain molecules can fluoresce,
 and each molecule has a unique excitation wavelength and emission
 wavelength(s). Fluorescence varies based on concentration of the
 fluorophore and presence of a quencher. 
Spectra, Intensity, and Stern-Volmer Plot 
The fluorescence intensity spectra for data collected in one
 concentration of the quencher shows the fluorescence
-enhancing effects of β-Cyclodextrin. In order to find the
 association constant of β-Cyclodextrin and propranolol in the
 presence of KI, the inverse of the difference between the
 intensity (sans iodide or β-CD) and the observed intensity at a
 given condition. This was done according to the equation
 below. The Stern-Volmer plot usually gives the association
 constant and “Stern-Volmer constants” but more data is
 needed. 
Fluorometric Analysis 
Cyclodextrins are used in a variety of ways, most often in
 industrial and pharmacoligical applications. They are cyclic
 oligosaccharides that range from 6 to 100+ units in size; β-
 and γ-cyclodextrins have 6 and 7 units, respectively. They
 are capable of inclusion complexes with various molecules,
 particularly due to their cone-shaped ring structure.
 Complexation can aid in a number of functions, such as
 enhancing fluorescence in the presence of a quencher. 
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